Overview of the 2011 food and drug administration circulatory system devices panel of the medical devices advisory committee meeting on the Edwards SAPIEN™ transcatheter heart valve

Circulation

Volumn 125, Issue 3, 2012, Pages 550-555

  Barbash, Israel M ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

aortic stenosis; Food and Drug Administration; transcatheter heart valve

Indexed keywords

ADVISORY COMMITTEE; ANTICOAGULANT THERAPY; AORTA STENOSIS; AORTIC VALVE REPAIR; ARTICLE; CARDIOVASCULAR EQUIPMENT; FOOD AND DRUG ADMINISTRATION; HEART HEMODYNAMICS; HEART VALVE; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STROKE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSCATHETER HEART VALVE; TREATMENT INDICATION; TREATMENT OUTCOME;

DEVICE APPROVAL; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84856442831     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.059873     Document Type: Article

References (9)

1. Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous course of aortic valve disease. Eur Heart J. 1987;8:471-483. (Pubitemid 17093278)
2. Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, Schmitz W, Kubler W. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105-1110. (Pubitemid 12036848)
3. Chizner MA, Pearle DL, deLeon AC Jr. The natural history of aortic stenosis in adults. Am Heart J. 1980;99:419-424. (Pubitemid 10009588)
4. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg. 2006;82:2111-2115.
5. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
6. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198.
7. US Food and Drug Administration. Briefing document for the Circulatory Systems Device Panel Advisory Committee. Presented July 20, 2011, Gaithersburg MD. http://www.Fda.Gov/downloads/advisorycommittees/committeesmeetingmaterials/ medicaldevices/medicaldevicesadvisory committee/circulatorysystemdevicespanel/ ucm262935.pdf. Accessed July 21, 2011.
8. US Food and Drug Administration. Summary of safety and effectiveness data. Presented July 20, 2011, Gaithersburg MD. http://www.Fda.Gov/downloads/ advisorycommittees/committeesmeetingmaterials/medicaldevices/ medicaldevicesadvisorycommittee/circulatorysystemdevicespanel/ucm262936. pdf. Accessed July 21, 2011.
9. US Food and Drug Administration. FDA Executive Summary: Edwards SAPIEN THV. Presented July 20, 2011, Gaithersburg, MD. http://www. Fda.Gov/downloads/ advisorycommittees/committeesmeetingmaterials/medicaldevices/ medicaldevicesadvisorycommittee/circulatorysystemdevices panel/ucm262930.pdf. Accessed July 21, 2011.